Fujifilm Holdings Corp. said Friday one of its subsidiaries has applied for government approval to market the anti-viral drug Avigan for COVID-19 treatment in Japan.The filing by Fujifilm Toyama Chemical Co. with Japan's health ministry came after clinical tests showed the drug reduces the recovery time for patients with non-severe cases of COVID-19, the respiratory disease caused by the novel coronavirus.Related coverage:Japan to seek int'l rules on states' response to infection-hit shipsJapan already planning approval of antiviral drug Avigan in Nov.READ FULL ARTICLE